Drug manufacturer Pfizer has moved to recall several lots of blood pressure pills over concerns that the medication may have been tainted with a carcinogenic contaminant. The affected medications include Accuretic, which is a tablet distributed by Pfizer itself, as well as a line of medications distributed by a second manufacturer known as Greenstone. The Greenstone lots include a pill that combines quinapril hydrochloride and hydrochlorothiazide ...
All Eyes on California as $50 Billion Opioid Trial Sets Stage for What’s to Come
Posted June 9, 2021 in Drug and Medical Device Lawsuits | Product News and Recalls
Four California counties are demanding $50 billion from Johnson & Johnson, Teva Pharmaceutical Industries, Endo International Plc, and Allergan Plc for their roles in marketing and distributing powerful opioid narcotics throughout their communities. And, as thousands of other municipalities and localities wait to have their own days in court to hold pharmaceutical manufacturers responsible, both sides are paying very close attention to what happens in the California ...
First Trial Scheduled in Opioid MDL
Posted June 1, 2018 in Drug and Medical Device Lawsuits | Product News and Recalls
The judge overseeing the MDL that seeks to hold drug manufacturers and distributors responsible for their roles in the nation’s ongoing opioid abuse epidemic has scheduled the first cases in the litigation for trial. If all goes to plan, some very serious questions might start seeing answers beginning in March of next year.
U.S. District Judge Daniel Polster had, to this point, sought ...
continue reading...Teva Suspends Zecuity Sales
Posted June 23, 2016 in Drug and Medical Device Lawsuits | Product News and Recalls
Just nine months after bringing Zecuity to market, Teva Pharmaceuticals has suspended all sales activity surrounding their new migraine relief patch. This includes marketing as well as distribution.
Zecuity’s launch has gone far worse than expected for Teva. The FDA issued a safety alert regarding the migraine relief patch earlier this month after a “large number of patients” experienced burns and scarring on the patch site.
Zecuity was intended ...
continue reading...Migraine Patch May Cause Severe Burns and Scarring
Posted June 13, 2016 in Drug and Medical Device Lawsuits | Product News and Recalls
For the 36 million Americans that suffer from migraines, any chance at relief is a chance worth considering – at the very least. The debilitating headaches can strike anywhere from 10 to 14 days a month for chronic suffers and the effects can be anything from extreme sensitivity to light to nausea and vomiting. Migraines are far more than just regular headaches.
Various prescription pain relievers are available to ...
continue reading...Androgel Manufacturer Drops Plan to Purchase Shire
Posted February 23, 2015 in Product News and Recalls | Testosterone Therapy
First Word Pharma reports that Androgel maker AbbVie has abandoned its plan to buy out pharmaceutical maker Shire. AbbVie says the bid for Shire was withdrawn in light of recent U.S. tax law changes. As a result of the failed deal, AbbVie will have to pay $1.6 billion to Shire and will be unable to make another offer to purchase the company for at least a year.
The Androgel maker was recently in the news over ...
continue reading...
